期刊名：Antibodies

期刊主页：https://www.mdpi.com/journal/antibodies

本期编辑荐读为您精选2024年发表于 Antibodies 期刊的十篇编辑精选文章。希望能为相关领域学者提供新的思路和参考，欢迎阅读。

1.

英文标题: Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria

中文标题: 灾难性抗磷脂综合征的诊断和治疗以及2023年ACR/EULAR抗磷脂综合征分类标准的潜在影响

文章链接: https://www.mdpi.com/2073-4468/13/1/21

MDPI引用格式: Jacobs, L.; Wauters, N.; Lablad, Y.; Morelle, J.; Taghavi, M. Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. Antibodies 2024, 13, 21.

2.

英文标题: Antiphospholipid Antibodies Associated with Native Arteriovenous Fistula Complications in Hemodialysis Patients: A Comprehensive Review of the Literature

中文标题: 抗磷脂抗体与血液透析患者自体动静脉瘘并发症的关系：文献综述

文章链接: https://www.mdpi.com/2073-4468/13/1/1

MDPI引用格式: Taghavi, M.; Jabrane, A.; Jacobs, L.; Mesquita, M.D.C.F.; Demulder, A.; Nortier, J. Antiphospholipid Antibodies Associated with Native Arteriovenous Fistula Complications in Hemodialysis Patients: A Comprehensive Review of the Literature. Antibodies 2024, 13, 1.

3.

英文标题: Immune-Mediated Necrotizing Myopathy (IMNM): A Story of Antibodies

中文标题: 免疫介导性坏死性肌病（IMNM）：抗体的故事

文章链接: https://www.mdpi.com/2073-4468/13/1/12

MDPI引用格式: Julien, S.; Challier, I.; Malleter, M.; Jouen, F.; Drouot, L.; Boyer, O. Immune-Mediated Necrotizing Myopathy (IMNM): A Story of Antibodies. Antibodies 2024, 13, 12.

4.

英文标题: SARS-CoV-2: A Glance at the Innate Immune Response Elicited by Infection and Vaccination

中文标题: SARS-CoV-2：感染和疫苗接种引发的先天免疫反应概览

文章链接: https://www.mdpi.com/2073-4468/13/1/13

MDPI引用格式: Manfrini, N.; Notarbartolo, S.; Grifantini, R.; Pesce, E. SARS-CoV-2: A Glance at the Innate Immune Response Elicited by Infection and Vaccination. Antibodies 2024, 13, 13.

5.

英文标题: A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments

中文标题: 皮肤T细胞淋巴瘤CCR4靶向治疗现状综述：聚焦莫加莫利珠单抗及未来治疗

文章链接: https://www.mdpi.com/2073-4468/13/2/32

MDPI引用格式: Zengarini, C.; Guglielmo, A.; Mussi, M.; Motta, G.; Agostinelli, C.; Sabattini, E.; Piraccini, B.M.; Pileri, A. A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments. Antibodies 2024, 13, 32.

6.

英文标题: TLR2 and TLR9 Blockade Using Specific Intrabodies Inhibits Inflammation-Mediated Pancreatic Cancer Cell Growth

中文标题: 利用特异性抗体阻断TLR2和TLR9可抑制炎症介导的胰腺癌细胞生长

文章链接: https://www.mdpi.com/2073-4468/13/1/11

MDPI引用格式: Ajay, A.K.; Gasser, M.; Hsiao, L.-L.; Böldicke, T.; Waaga-Gasser, A.M. TLR2 and TLR9 Blockade Using Specific Intrabodies Inhibits Inflammation-Mediated Pancreatic Cancer Cell Growth. Antibodies 2024, 13, 11.

7.

英文标题: Anti-MET Antibody Therapies in Non-Small-Cell Lung Cancer: Current Progress and Future Directions

中文标题: 抗MET抗体疗法在非小细胞肺癌中的应用：现状与未来方向

文章链接: https://www.mdpi.com/2073-4468/13/4/88

MDPI引用格式: Wang, K.; Hsu, R. Anti-MET Antibody Therapies in Non-Small-Cell Lung Cancer: Current Progress and Future Directions. Antibodies 2024, 13, 88.

8.

英文标题: Enhanced Characterization of Lysine-Linked Antibody Drug Conjugates Enabled by Middle-Down Mass Spectrometry and Higher-Energy Collisional Dissociation-Triggered Electron-Transfer/Higher-Energy Collisional Dissociation and Ultraviolet Photodissociation

中文标题: 利用中低能质谱和高能碰撞解离触发电子转移/高能碰撞解离和紫外光解离技术增强赖氨酸连接抗体药物偶联物的表征

文章链接: https://www.mdpi.com/2073-4468/13/2/30

MDPI引用格式: Watts, E.; Bashyal, A.; Dunham, S.D.; Crittenden, C.M.; Brodbelt, J.S. Enhanced Characterization of Lysine-Linked Antibody Drug Conjugates Enabled by Middle-Down Mass Spectrometry and Higher-Energy Collisional Dissociation-Triggered Electron-Transfer/Higher-Energy Collisional Dissociation and Ultraviolet Photodissociation. Antibodies 2024, 13, 30.

9.

英文标题: Balancing the Affinity and Tumor Cell Binding of a Two-in-One Antibody Simultaneously Targeting EGFR and PD-L1

中文标题: 平衡同时靶向 EGFR 和 PD-L1 的二合一抗体的亲和力和肿瘤细胞结合能力

文章链接: https://www.mdpi.com/2073-4468/13/2/36

MDPI引用格式: Harwardt, J.; Geyer, F.K.; Schoenfeld, K.; Baumstark, D.; Molkenthin, V.; Kolmar, H. Balancing the Affinity and Tumor Cell Binding of a Two-in-One Antibody Simultaneously Targeting EGFR and PD-L1. Antibodies 2024, 13, 36.

10.

英文标题: Functional Activity of Cytokine-Induced Killer Cells Enhanced by CAR-CD19 Modification or by Soluble Bispecific Antibody Blinatumomab

中文标题: CAR-CD19修饰或可溶性双特异性抗体Blinatumomab可增强细胞因子诱导的杀伤细胞的功能活性

文章链接: https://www.mdpi.com/2073-4468/13/3/71

MDPI引用格式: Zaninelli, S.; Panna, S.; Tettamanti, S.; Melita, G.; Doni, A.; D’Autilia, F.; Valgardsdottir, R.; Gotti, E.; Rambaldi, A.; Golay, J.; et al. Functional Activity of Cytokine-Induced Killer Cells Enhanced by CAR-CD19 Modification or by Soluble Bispecific Antibody Blinatumomab. Antibodies 2024, 13, 71.